Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.
Diners eat at Mowgli restaurant at Westgate to raise funds for patients oxfordmail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oxfordmail.co.uk Daily Mail and Mail on Sunday newspapers.
Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021 Financial Results and Provides Corporate Update
May 20, 2021 08:00 ET | Source: Replimune Group Inc Replimune Group Inc Woburn, Massachusetts, UNITED STATES
Added complete response as an independent primary endpoint in registration-directed CERPASS study in CSCC and held Type B meeting with FDA to discuss the IGNYTE study in anti-PD1 failed melanoma
Dosed first patient with RP1 in the anti-PD1 failed NSCLC lung cancer cohort of the IGNYTE study
Data update on lead programs to be provided during virtual investor event on June 3, 2021
Strengthened management team to prepare for potential commercial launch and enable further later stage development
State-of-art robotic cancer surgery in Oxfordshire hospitals oxfordmail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oxfordmail.co.uk Daily Mail and Mail on Sunday newspapers.